Loading GH...
Guardant Health Inc.GHAs of 31 July 2026
+81
PositiveNegative
Negative skew
Valuation
Is Guardant Health Inc. undervalued or overvalued?
Where Guardant Health Inc. (GH) trades across 21 valuation metrics, from price-to-sales and forward P/E to book and cash-flow multiples, each ranked against its own five-year history rather than a broad sector average, so you can see whether it is genuinely cheap or expensive on its own terms. Information, not advice.
Guardant Health Inc.GHLast 5 years
V—E—F—A—
——
GH priceasymmetryquant.com